Kee Woong Kwon

11PUBLICATIONS
31CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsGene and molecular therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 01, 2026
Cholesterol 25-Hydroxylase Deficiency Provides an Optimal and Durable Protective T Helper 1 Immunity via Interleukin-12-Interleukin-2 Axis in BCG-Vaccinated Mice.

|Oct 06, 2025
Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosis.

Kee Woong Kwon, Tae Gun Kang, Jii Bum Lee

|Mar 08, 2024
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice.

Kee Woong Kwon, Han-Gyu Choi, Kwang Sung Kim

|May 14, 2023
Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection.

Kee Woong Kwon, Tae Gun Kang, Ara Lee

|Aug 30, 2022
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection.

Lee-Han Kim, Soon Myung Kang, Jake Whang

|Jun 07, 2022
Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx.

Tae Gun Kang, Kee Woong Kwon, Kyungsoo Kim

Pageof 2

Frequent Collaborators

10 joint publications

Sung Jae Shin

3 joint publications

Sang-Jun Ha

3 joint publications

Jumi Lee

3 joint publications

Lee-Han Kim